NewSplash
join our newsletterCurrent Healthcare News
Welcome to NewSplash
Catch up on current healthcare news and find useful blog content from experts in the sterile processing world. Sign up below to never miss an article.
Stay up-to-date with industry-related news and articles in our weekly NewSplash!
AAMI ST108: Filters and Your Water Supply
Filters are the first line of defense against the crud in your municipal water supply and are necessary for meeting utility and critical water standards.
Rising Threat of Antimicrobial-Resistant Fungus in Healthcare
A fungus considered an urgent antimicrobial resistance threat spread at an alarming rate in US healthcare facilities in 2020-2021, according to the CDC.
Study: Mild fever helps infection clear faster
It may be better to let a mild fever run its course instead of automatically reaching for medication, new University of Alberta research suggests.
SARS-CoV-2 weakens immune-cell response to vaccine
An NIH-funded study suggests that SARS-CoV-2 damages an important immune-cell response, leading to lower vaccine protection than those never infected.
Pfizer Migraine Nasal Spray Receives FDA Approval
Zavzpret is the first and only calcitonin gene-related peptide (CGRP) receptor antagonist nasal spray for the acute treatment of migraine in adults.
CDC recommends hepatitis B screening for all adults
The US Centers for Disease Control and Prevention (CDC) recommended universal hepatitis B (HBV) screening for adults, regardless of risk factors.
Venous blood clots rare among COVID-19 outpatients
A study of nonhospitalized adults found a low rate of venous thromboembolism (VTE, or a blood clot in a vein) in the 30 days after COVID-19 diagnosis.
Short-Term Gains or Long-Term Change?
Did you truly solve your SPD’s problem, or are you experiencing the Hawthorne effect—people changing their behavior because they are aware of being observed?
FDA advisers recommend Pfizer RSV vax for 60+
The FDA vaccine advisory group recommended approval of Pfizer’s respiratory syncytial virus (RSV) vaccine for use in people 60 and older.
Rise in extensively drug-resistant Shigella, CDC warns
The CDC said 5% of Shigella infections in 2022 were caused by XDR strains, which are resistant to commonly recommended antibiotics. That’s up from 0% in 2015.